Why Use the Robotic System for the Esophageal Cancer in Minimally Invasive Surgery Era?—Current Status of Robotic Esophagectomy in the World—
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 1338
Special Issue Editors
Interests: surgical oncology for esophageal cancer
Special Issue Information
Dear Colleagues,
Minimally Invasive Esophagectomy (MIE) in the left lateral and prone position was first reported in the 1990s. The prone position can provide direct viewing of the esophagus without organ compression and provides a stable and wide operative field, the anatomy of the mediastinum has become better understood in esophagectomy. Therefore, the transthoracic approach of MIE in the prone position has been widely accepted and has helped standardize esophagectomy, even in complicated operations. MIE has already become the standard surgical procedure overseas because of its advantages over OPEN thoracotomy; MIE can provide both early recovery after esophagectomy for the patient and an understanding of the anatomy of the surgeon. Moreover, MIE has already begun a paradigm shift toward robotic esophagectomy. This is because the robotic surgical system can facilitate precise surgical techniques by the robotic end-list function and provide magnified microanatomy by the robotic 3D high solution endoscopy. Robotic esophagectomy is still in the implementation phase overseas, and several robotic advantages over OPEN and thoracoscopic esophagectomy have been reported. Cancers will feature robotic-assisted MIE in the double 20 era and inform the current status of robotic esophagectomy in each country, but why use a robotic system for esophageal cancer in the era of minimally invasive surgery?
Dr. Hiroyuki Daiko
Prof. Dr. Yin-Kai Chao
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- esophageal cancer
- esophagectomy
- robotic surgery
- robotic esophagectomy
- Minimally Invasive Esophagectomy
